Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Analytical Biochemistry|June 10, 2006
Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technologyIva Navratilova, Marianna Dioszegi, David G MyszkaMolecular Pharmacology|December 22, 2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonistsRama Kondru, Jun Zhang, Changhua Ji, et al.Molecular Pharmacology|March 30, 2007
CCR5 small-molecule antagonists and monoclonal antibodies exert potent synergistic antiviral effects by cobinding to the receptorChanghua Ji, Jun Zhang, Marianna Dioszegi, et al.Antimicrobial Agents and Chemotherapy|January 24, 2007
The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodiesJun Zhang, Eileen Rao, Marianna Dioszegi, et al.Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.Antiviral Research|December 15, 2006
Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activitiesChanghua Ji, Michael Brandt, Marianna Dioszegi, et al.British Journal of Pharmacology|March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligandsDavid C Swinney, Paul Beavis, Kai-Ting Chuang, et al.Antimicrobial Agents and Chemotherapy|February 9, 2011
Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strainsJürgen Schanzer, Andreas Jekle, Junichi Nezu, et al.Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.Bioorganic & Medicinal Chemistry Letters|April 27, 2010
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.Pageof 1